The object of this study was to assess functional maturation in vitro by obtaining data on the fertilization and embryonic competence of human oocytes with or without exposure to meiosis activating sterol (MAS) during maturation in vitro. Immature oocytes were either collected from unstimulated patients with polycystic ovaries (PCO) during gynaecological surgery, or were donated by patients undergoing a cycle of intracytoplasmic sperm injection (ICSI) treatment including ovarian stimulation with gonadotrophins. PCO oocytes had variable cumulus cover, which was retained during culture while those from ICSI patients were cultured without cumulus. The study included 119 oocytes from PCO patients and 72 from ICSI patients. The oocytes were allowed to mature in vitro for up to 46 h in the presence or absence of MAS. Mature oocytes were inseminated by ICSI with fertile donor spermatozoa and embryo development was monitored in vitro. MAS (30 µg/ml) significantly increased the survival of oocytes from PCO patients (P < 0.01) but did not significantly affect the proportion completing maturation in vitro. For the ICSI patients, >90% of oocytes survived in all culture groups, regardless of MAS addition, however MAS (10 or 30 µg/ml) significantly increased the proportion of oocytes maturing in vitro (P < 0.05). The apparent tendency towards improved subsequent development in vitro will require larger numbers of oocytes for evaluation. Oocytes from ICSI patients matured more rapidly in vitro than those from PCO patients. Our results show positive effects of MAS on human oocytes, confirming previous data in mice. This work may have implications for the future clinical application of IVM.
Introduction
potential relies upon an appropriate follicular environment and the type of follicle from which the oocyte originates is crucial The final 36 h of human oocyte formation are critical for the for its subsequent function. It has been known for many years normal functioning of the resulting gamete. During this time, that immature human oocytes removed from large follicles oocytes resume meiosis from their prenatal arrest in diplotene will mature spontaneously (Edwards, 1965a,b) ; however, the and progress to metaphase II (MII). They also undergo 'cytodevelopmental competence of in-vitro matured (IVM) human plasmic maturation', a poorly defined process, in preparation oocytes is low (Veeck et al., 1983; Barnes et al., 1996 ; Coskun for fertilization and early embryo development, which largely et al., 1998) , probably due to disruption of the normal depends upon oocyte constituents until after embryonic genome activation. Prior readiness of the oocyte to progress through follicular control mechanisms regulating this important stage the final maturation phase and attain its full developmental of development. For this reason, in-vivo maturation has been preferred for oocyte preparation for IVF, despite the need for large doses of exogenous hormones, with their attendant risks *Presented in part at the British Fertility Society Conference, Sheffield, and costs (Russell, 1999) . This is in contrast to some animal UK, 15-17 April 1998 , and at the 15th meeting of the European species where IVM is commonly used to obtain viable oocytes for research or commercial purposes .
Immature oocyte retrieval combined with IVM could offer hormonal stimulation (Wynn, et al., 1998; Chian et al., 1999;  Data not recorded 2 Jaroudi et al., 1999) . The content of the medium used for IVM
No of oocytes collected a may also affect the outcome. A key experiment in the 1990s, Live 7.0 Ϯ 4.1 (1-19) Atretic 4. 9 Ϯ 3.7 (0-14) which re-awakened interest in human IVM, used human follicular fluid to supplement the culture medium (Cha et al., a Values are presented as mean Ϯ SD, with range in parentheses.
1991) but, with the growing preference for defined media, the roles of individual factors are now being assessed and the inclusion of biological fluids is declining. Cha and Chian, 1998) .
No. of 2PN frozen 1.5 Ϯ 1.7
Meiosis activating sterols (MAS) have been purified from
No. of immature oocytes donated to 2.6 Ϯ 0.9 (1-6) study human follicular fluid 14, fluid at concentrations of~1.3 µmol/l, and is an intermediary e Oocytes with two pronuclei (2PN)/oocytes injected.
occurring naturally in the biosynthetic pathway between lanosterol and cholesterol (Byskov et al., 1995) . It activates meiotic example, allowing rapid oocyte collection in women with resumption of both cumulus-enclosed and denuded mouse cancer who cannot spend time undergoing a normal IVF cycle oocytes in vitro (Byskov et al., 1995 (Byskov et al., , 1999 ; Hegele-Hartung before sterilizing chemotherapy. The potential of an embryo et al., 1999) . MAS is synthesized by cumulus cells of intact largely reflects the competence of the oocyte and it might oocyte-cumulus-complexes in response to FSH stimulation become possible, in future, to select immature oocytes with (Byskov et al., 1998) and the concentrations of MAS in prethe greatest potential before fertilization, avoiding some of the ovulatory follicular fluid samples are correlated with the ability ethical dilemmas of embryo selection. of the associated oocyte to fertilize and cleave (Byskov et al., These factors, together with the developing knowledge on 1998). A histological study of 81 human oocytes suggested mechanisms controlling follicle and oocyte growth and early that the completion of maturation in vitro might be promoted embryology suggest that the time is right for IVM to be by FF-MAS (Grøndahl et al., 2000) . Our focus has been to applied with caution in patient treatment. We have performed assess functional maturation by obtaining data on the fertilizathis preclinical research study to assess the effects of meiosis tion and embryonic competence of human oocytes after FFactivating sterol (FF-MAS), a naturally occurring stimulator MAS exposure during IVM. No data on this subject have been of meiosis, upon the maturation and preimplantation developpublished previously. ment of immature human oocytes from two different sources: The prevalence of polycystic ovaries (PCO) in 'normal' (i) unstimulated patients with PCO and (ii) patients undergoing adult women is~20% (Polson et al., 1988; Clayton et al., a fully stimulated cycle of ICSI treatment. 1992). PCO may be associated with infertility and such patients may be hyper-responsive to the gonadotrophin stimulation normally used for IVF. A classical polycystic ovary has several Materials and methods antral follicles up to~10 mm diameter around the periphery Oocytes from two groups of patients were studied: (i) those with of the ovary. Although these follicles are not actively growing, unstimulated PCO and (ii) those undergoing ICSI treatment, which they contain immature oocytes which may be capable of included ovarian stimulation according to a standard 'long' downfurther development (Trounson et al., 1994; Chian et al., There may be additional potential benefits from IVM, for Unstimulated PCO patients ooplasm, and any other features of oocyte morphology. Oocytes obscured by tightly surrounding cumulus cells (cumulus enclosed; These patients were attending gynaecology or infertility clinics at the CE) were presumed to contain a GV. The initial assessment of Walsgrave Hospital, Coventry. Patients having symptoms of PCO maturity was performed~2 h after oocyte retrieval. (Adams et al., 1986) and who were undergoing treatment, including Images of oocytes were collected daily via a video link on an laparoscopy, were invited to participate in the study.
inverted high power microscope (Olympus IX 70) employing Hoffman Inclusion criteria were: (i) PCO, diagnosed primarily by the optics and Image Pro-plus software. Oocytes which were clearly ultrasound appearance of the ovaries, but additionally by a history of atretic on collection, e.g. dark cytoplasm and irregular shape, were oligomenorrhoea or amenorrhoea, and blood hormone measurements; noted before discarding. (ii) no drug therapy for infertility in the 4 months before surgery; and (iii) requiring diagnostic laparoscopy and/or laser drilling of the ICSI patients ovaries. Patients wishing to participate provided written consent.
Immature oocytes were donated by women undergoing ICSI at the Laparoscopy was scheduled irrespective of the stage of the menCentre for Reproductive Medicine, Walsgrave Hospital. Women strual cycle.
wishing to participate gave written consent prior to the oocyte retrieval. Patient preparation, oocyte retrieval and embryological Retrieval of immature oocytes procedures were performed using the centre's standard protocols Oocyte retrieval procedures were carried out in the afternoon in (Garello et al., 1999) . Any immature oocytes identified when oocytes theatres on the same site but separate from the main embryology were stripped of cumulus in preparation for ICSI were randomly laboratory. A previously described technique (Trounson et al., 1994) allocated to MAS treatment groups using random number tables; was followed using a purpose-designed 17 gauge needle (Cook IVF, thereafter, they were treated identically to oocytes from PCO patients. Letchworth, UK) and a laparoscopic approach. All visible follicles
Oocytes were considered immature if they contained a GV or had were punctured and aspirated using 80-100 mmHg suction. Measureundergone germinal vesicle breakdown (GVBD) but had not released ment of follicular diameter was not possible by direct laparoscopic a polar body. inspection since the follicles were relatively small (Ͻ10 mm) and the stroma was dense. The fluid was collected into 10 ml sterile
Meiosis activating sterol (FF-MAS) plastic tubes (Fahrenheit Laboratory Supplies, Milton Keynes, UK)
FF-MAS was purified from human follicular fluid as described containing 2 ml pre-warmed, heparinized (3 IU/ml; Leo Laboratories (Byskov et al., 1995; Baltsen and Byskov, 1999) . MAS was stored at -20°C in n-heptane under N 2 in glass vials. Before use, a stream Ltd, Buckinghamshire, UK) Ham's F10 medium (ICN Pharmaceutof nitrogen gas was used to evaporate the heptane from a known icals Ltd, Thame, UK) buffered with 20 mmol/l HEPES and supplequantity of MAS which was dissolved in a known small volume of mented with 0.5% human serum albumin (HSA; Immuno Ltd, Dunton absolute ethanol (EtOH) and added to the prepared IVM media in Green, UK). The aspirates were maintained at 37°C in a thermostatic glass tubes to final concentrations of 10 and 30 µg/ml (24.4 and hot-block (Grant, Cambridge, UK) and transported to the embryology 73.2 µM). EtOH alone, treated in the same manner, was added to laboratory in a portable incubator (Cell Trans 4016 Transport Incubcontrols. All wells contained a final concentration of 0.5% EtOH. ator; Labotech). The oocyte aspiration procedure took~40 min and MAS/EtOH was added to the cultures~1 h before oocyte retrieval. the journey Ͻ10 min.
Volumes of 100 µl IVM medium containing the various concentraFollicular aspirates were placed into an Em-Con filter of 75 µm tions of MAS were set up in a sterile 96-well plate (Nunclon) which pore size (Immuno Systems, Spring Valley, WI, USA) which had also contained medium in the surrounding wells to increase humidity been pre-rinsed with warmed heparinized Ham's F10 medium as and reduce evaporation. Cultures were housed in a humidified above. The aspirates were flushed with 250 ml of the same medium incubator (37°C, 5% CO 2 in air). An oil overlay was not used, to remove contaminating blood cells and the filter retentate was thus avoiding oil phase extraction of MAS. Control experiments transferred to sterile dishes (Falcon, Fahrenheit) .
demonstrated that the osmolarity of cultures maintained under these Oocyte-cumulus masses and free oocytes were identified using a conditions varied by Ͻ1% after 24 h. dissecting microscope (Leica Microsystems, Milton Keynes, UK), Up to four oocytes were co-incubated in each well. The oocytes equipped with a heated stage, and transferred to tissue culture dishes were examined after 23-24 h and their maturational stage recorded. (Nunclon; Gibco, Life Technologies, Paisley, UK) containing 2 ml Oocytes which had extruded a polar body were considered mature IVM medium. IVM medium comprised Medium 199 (Gibco) suppleand removed for ICSI. 40-48 h after initiation of culture, any mented with 0.23 mmol/l sodium pyruvate (Sigma, Poole, UK), 50 remaining cumulus cells were removed by pipetting and all oocytes IU/ml penicillin G and 50 µg/ml streptomycin (Gibco). The IVM were assessed microscopically. Mature oocytes were injected with medium was prepared on the morning of oocyte retrieval and dishes known fertile donor spermatozoa according to the Centre's established of medium were pre-equilibrated in a humidified incubator at 37°C, ICSI protocol (Garello et al., 1999) . Frozen stored spermatozoa from containing 5% CO 2 in air. The preparation of MAS-containing IVM two fertile donors were used for the entire study. medium is explained below.
After injection, oocytes were transferred individually to S1 or G1 The level of cumulus cover surrounding the oocyte was graded medium (Scandinavian IVF Science, Sweden) in 100 µl drops under subjectively from 0-3, where 0 ϭ devoid of cumulus; 1 ϭ partially oil (Ovoil; Scandinavian IVF Science). Dishes were pre-equilibrated covered zona; 2 ϭ completely covered zona; and 3 ϭ substantial at 37°C in an atmosphere of 5% CO 2 in air for 1 day before use. The multi-layered cumulus cover. Individual viable oocytes were randomly oocytes were checked for fertilization 14-18 h post-injection using allocated to one of three concentrations of MAS using tables of standard procedures of pronuclear assessment. Zygotes and cleaving random numbers.
embryos were observed and moved to fresh drops daily. Computerized An oocyte was considered to be viable if it had an intact oolemma, photographic images were collected each day until the embryo a light coloured cytoplasm and a regular-appearing spherical shape.
arrested or degenerated. In previous experiments using the fluorescent vital stains, carboxyStatistical analyses fluorescein diacetate (CFDA) and propidium iodide (PI), these features had been confirmed as identifying viable oocytes. Where possible, it
The proportions of oocytes in groups exposed to different concentrations of MAS were compared using p ϫ q χ 2 test (Campbell, 1989) . was recorded whether a germinal vesicle (GV) was present in the (ICSI) patients. GV ϭ germinal vesicle; GVBD ϭ germinal vesicle breakdown; CE ϭ cumulus enclosed (GV assumed, but not visible). a Significantly different (P Ͻ 0.01). Scatter plots were assessed for correlation using regression analysis. P Ͻ 0.05 was considered to be statistically significant. Student's was not associated with an alteration in the proportion of t-test was used to compare the numbers of viable oocytes in the two surviving oocytes which matured, which remained at~45%. patient groups. Figure 2 shows the results of MAS exposure of immature oocytes from ICSI patients. Oocyte survival was Ͼ90% in all Results groups, regardless of MAS concentration. However, in this patient group, the presence of MAS at 10 or 30 µg/ml A total of 119 viable immature oocytes were collected from 17 PCO patients with unstimulated ovaries and 72 immature significantly increased the proportion of oocytes maturing (P Ͻ 0.05). oocytes were donated by 28 ICSI patients. Clinical details of the patient groups are presented in Tables I and II. The proportions of maturing oocytes fertilized by ICSI and subsequently cleaving in either PCO or ICSI groups are Figure 1 shows the results of MAS exposure of oocytes obtained from PCO patients. MAS at a concentration of presented in Tables III and IV , but the apparent differences were not tested statistically in view of the low numbers of 30 µg/ml significantly increased oocyte survival (P Ͻ 0.01, p ϫ q χ 2 test, Campbell, 1989); 90% survival in 30 µg/ml oocytes reaching this stage. Figure 3 shows that significantly more immature oocytes compared with 62 and 63% for 10 µg/ml and control respectively. The increased survival of oocytes in 30 µg/ml MAS per patient were obtained from PCO patients in comparison oocytes. In the ICSI group, atresia was confined to oocytes collected at the GV stage. The time course of oocyte maturation was different in the (89%) of PCO oocytes that matured to MII, did so on the second day of IVM culture. with ICSI patients (P Ͻ 0.01), but surprisingly, there was no There was no significant relationship between the numbers significant difference in the proportion of oocytes that had of viable or atretic oocytes collected and patient age in PCO undergone GVBD between the PCO and ICSI patient groups. patients (r ϭ 0.141 and 0.268 respectively), as shown in Figure  Figures 4 and 5 show the maturation in vitro to MII of 8. Similarly, there was no relationship between the number of oocytes collected at the GV and GVBD stages for both patient viable oocytes and the number of days since the last menstrual groups. In PCO patients (Figure 4) , the proportion of oocytes period (r ϭ 0.040) or patient weight (r ϭ 0.264) in the PCO in both categories reaching MII was highly variable. Cultured patients (data not shown). immature oocytes from ICSI patients had a low maturation rate (either GV or GVBD at collection) but this was improved Discussion by addition of MAS, as shown in Figure 5 . For the oocytes that failed to mature in the ICSI group, approximately equal Our results demonstrate, for the first time, the significant effects of MAS on in-vitro survival and maturation of human numbers arrested at or after the GV stage. Figure 6 shows the rates of atresia occurring in vitro after oocytes. Immature oocytes collected from two different patient groups, unstimulated PCO patients and stimulated ICSI collection of apparently viable oocytes. Especially high levels of atresia were noted in GVBD oocytes from PCO patients.
patients, have been shown to differ in terms of oocyte function in vitro, including the proportions maturing and the speed of Overall the PCO oocytes appeared more susceptible than ICSI has shown that even concentrations Ͻ1% EtOH can adversely affect bovine IVM and subsequent embryo development (Avery and Greve, 2000) . Bovine oocytes contain more lipidic yolklike granules than human oocytes; however, it is possible that some of the limited development observed in our study may relate to our use of EtOH in the cultures. This would not, however, affect the validity of the results observed, since EtOH was included at a similar concentration in all cultures.
MAS is produced in cumulus cells (Leonardsen et al., 2000) . Its effects are likely to be mediated via mechanisms employed by other follicular steroids, perhaps in a manner similar to progesterone stimulation of meiosis in Xenopus oocytes (Byskov et al., 1998) . MAS receptors have not yet been identified; however, MAS is known to have direct actions upon mouse oocytes and does not depend upon mediation by cumulus cells (Byskov et al., 1995) , unlike, e.g. gonadotrophins. The steroid environment of follicles in PCO is disturbed (e.g. Almahbobi and Trounson, 1996; Pierro et al., 1997) , and so the influence of MAS in this environment might differ from other circumstances.
Immature oocytes retrieved from unstimulated PCO patients may or may not have cumulus cells covering them. The presence or absence of cumulus cells provides some indication of the follicle from which the oocyte originated, denuded oocytes being more likely to have arisen from atretic follicles. The known roles of cumulus cells include supporting oocyte growth and maintaining meiotic arrest throughout all immature expansion to facilitate the approach of spermatozoa to the zona pellucida at fertilization. Oocytes surrounded by cumulus cells may therefore be at an advantage during IVM culture. maturation in vitro. These differences may reflect patientrelated differences in the origin of the oocytes, including the Most enclosed oocytes had compact corona cells and contained a GV, and many of those without had progressed to GVBD, stage of follicle development at oocyte retrieval, the endocrine status or atresia of the follicles and the presence or absence probably as a result of incipient atresia in the follicle (Gougeon and Testart, 1986; Anderson et al., 1997) . Surprisingly, similar of supporting cumulus cells. These results will be important for the future application of IVM as a potential treatment in proportions of oocytes from PCO and ICSI patents had a GV or had undergone GVBD; however, these oocytes differed various clinical situations.
MAS significantly (P Ͻ 0.01) improved the survival of substantially in their predispositions towards atresia and their ability to mature to MII. The removal of cumulus cells from immature oocytes collected from unstimulated women with PCO. This is in contrast with the results obtained culturing immature oocytes collected from ICSI cycles might have affected some aspects of their development. immature oocytes from stimulated ICSI patients in whom FF-MAS did not affect oocyte survival (which was Ͼ90% in The mean number of viable oocytes collected from PCO patients was 7.0, which was lower than the means of 13.8 and this patient group), but maturation in vitro was significantly increased (P Ͻ 0.05). The variations in embryo development 13.1 obtained from anovulatory and ovulatory PCO patients respectively (Trounson et al., 1994) , but comparable with the in both patient groups with MAS supplementation of IVM media are also interesting, particularly in view of the compromaverage of 8.1 per patient reported in a later study (Coskun et al., 1998) . We did not find any specific characteristics of ised developmental competence which is widely believed to be associated with immature oocytes collected from PCO the PCO patients which were predictive of the numbers of oocytes retrieved; specifically, patient age, time since last patients, although statistical analysis was precluded by the limited numbers of oocytes reaching the later stages in our menstrual period, and weight showed no significant correlations. The number of oocytes collected would be expected to study.
There are some difficulties of working with steroids in vitro. reduce as the ovarian reserve declines with advancing age (Cha et al., 1991; Cha and Chian, 1998; Whitacre et al., 1998) ; We avoided the use of oil, which would extract the steroidal MAS, but we cannot exclude the possibility of it adhering to however, this was not our experience in this study. One group (Barnes et al., 1996) has previously reported the retrieval of the plastic culture vessel or being affected by albumin or other constituents in the culture medium. Similarly, the method of a larger number of oocytes from irregularly cycling and anovulatory patients compared to regularly cycling women dissolving steroids in EtOH is widely used, but recent evidence (16.5 and 4.9 respectively) which relates to the relative ease although the value of priming with low-dose FSH remains unclear (Wynn et al., 1998; Mikkelsen et al., 1999) . Others of aspiration from the peripherally located antral follicles in PCO. Extremes of weight are known to affect fertility; in have shown the relative effects of follicular versus luteal phase retrieval of oocytes (Cha and Chian, 1998; Whitacre et al., obese women with PCOS, fertility may be enhanced by a loss of weight. In this study, which included a range of obese and 1998), underlining the importance of the endocrine environment. In our study, PCO patients were not given any form of non-obese women, we observed no association between weight and oocyte yield.
hormonal manipulation prior to oocyte retrieval; however, it is likely that induction of a withdrawal bleed with or without Several studies have shown that oocytes aspirated after ovarian stimulation may be in various stages of maturation late follicular administration of HCG (Buckett et al., 1999; Chian et al., 1999) may improve the maturation rates achieved (Veeck et al., 1983; De Vos et al., 1999) . Oocytes that remain immature have failed to respond to ovarian stimulation in vivo in the present study. These methods still have the benefit of avoiding the major element of the drugs normally administered and may be of inherently reduced quality, they may have come from small follicles with reduced gonadotrophin sensitivity or for ovarian stimulation. Evidence is accumulating that MAS is an important endogenmay never have reached meiotic competence. Alternatively, they may have arisen from otherwise normal follicles which ous factor involved in promoting oocyte maturation. The data presented here show positive effects of MAS upon survival did not receive the same hormonal stimulus as others, perhaps due to their relative position in the ovary or limited blood and maturation of human immature oocytes collected from unstimulated PCO patients and stimulated ICSI patients supply. Moreover, the artificial conditions of gonadotrophin stimulation may have affected some aspects of their metabolism respectively. The limitations of a morphological assessment of viability are acknowledged, but the choice of criteria was or development (Johnson et al., 1991) . Nevertheless, it has been reported that these oocytes are capable of maturing supported by earlier experiments using vital stains. Clearly, the use of an invasive method in this study would have in vitro, fertilizing and developing normally (Cha and Chian, 1998 ). Our results demonstrate their responsiveness to stimulaprecluded the collection of data on further development. This is an important area since it is not yet known whether embryos tion with MAS, despite the absence of cumulus cells and their prior exposure to ovarian stimulation.
resulting from IVM in the presence of MAS have the potential to develop further or implant. In mouse cumulus cells, a heatThe importance of the endocrine environment in ensuring normal cytoplasmic maturation and subsequent fertilization is stable meiosis activating substance is stimulated by FSH (Byskov et al., 1997; Yding Andersen et al., 1999) and artificial well known from work in animals (Moor and Trounson, 1977; Anderiesz and Trounson, 1995) . The differing results obtained elevation of MAS in cumulus cells using inhibitors of specific enzymes on the steroid synthesis pathway promotes maturation in this study in patients with differing endocrine profiles underline the potential for IVM success rates to be affected of mouse oocytes in vitro (Leonardsen et al., 2000) . MAS was shown to improve immature oocyte function in mice by by the oocytes' prior exposure to physiological or pathological hormonal environments. In vitro, 28-30 h is required for the supporting microtubule assembly and delaying the release of cortical granules (Hegele-Hartung et al., 1999) . maturation of human oocytes to MI and 36-37 h to MII (Edwards, 1965a,b) . After HCG injection to simulate a LH Results were recently presented (Grøndahl et al., 1999 (Grøndahl et al., , 2000 of IVM of 81 human oocytes allocated into seven surge, the results are similar, the majority of the oocytes having extruded the first polar body by 36 h after HCG injection groups, with or without MAS, for histological analysis. These data showed a significant (P Ͻ 0.05) increase in the proportion (Janssenswillen et al., 1995) . One group (Jamieson et al., 1991) reported significantly lower IVF and cleavage rates of immature oocytes completing maturation after 30 h in vitro in the presence of 20 µmol/l MAS; however, at 22 and 40 h, in oocytes retrieved Ͻ36 h after the luteinizing stimulus, demonstrating the importance of appropriate timing of insemthe difference was not significant. Grøndahl's study differed from ours in several respects. His patient group had polycystic ination. Previous studies have shown that immature oocytes obtained from stimulated cycles are more likely to undergo ovaries, but received oral contraception for 2 months, to which was added a gonadotrophin-releasing hormone (GnRH) agonist maturation than unstimulated oocytes and that the time required for their maturation is reduced (Gomez et al., 1993a; Cha and for pituitary down-regulation, followed by recombinant FSH for 3 days. Follicles of 8-12 mm were aspirated on days 7-9 Chian, 1998). Our results concur with these prior observations. IVM can result in pregnancy (Cha et al., 1991;  Trounson and all oocytes were cumulus-enclosed throughout culture. These patients therefore underwent stimulation cycles. Also, et al., 1994; Barnes et al., 1995; Russell, 1998; Jaroudi et al., 1999) but rates remain lower than those of in-vivo stimulated half their aspirated oocytes were used for infertility treatment, although HCG was not administered. The medium used by cycles, indicating that optimization of IVM remains a challenge (Goud et al., 1998 et al., 1994) . This was apparent in our study: the most advanced embryo observed reached 6 cells with most embryos arresting inseminated.
In this study, we have demonstrated oocyte maturation with around the second cleavage division (3-4 cells). However, it appears that if the initiation of maturation is triggered in vivo, developmental competence as far as the second cleavage division. The effects of MAS on embryo development could then developmental potential increases (Chian et al., 1999) 
